Older Publications

FARAD Publications (Older) | No disponible en Español

Excretory, Secretory, and Tissue Residues after Label and Extra-label Administration of Flunixin Meglumine to Saline- or Lipopolysaccharide-Exposed Dairy Cows. J Agric Food Chem. 2015 May 20;63(19):4893-901
Tissue concentrations of sulfamethazine and tetracycline hydrochloride of swine (Sus scrofa domestica) as it relates to withdrawal methods for international export. Regul Toxicol Pharmacol. 2015 Apr;71(3):590-6
A Framework for Meta-Analysis of Veterinary Drug Pharmacokinetic Data Using Mixed Effect Modeling. J Pharm Sci. 2015 Apr;104(4):1230-9
Development and Application of a Multiroute Physiologically Based Pharmacokinetic Model for Oxytetracycline in Dogs and Humans J Pharm Sci. 2015 Jan;104: 233-243
Comparison of pharmacokinetics and milk elimination of flunixin in healthy cows and cows with mastitis. J Am Vet Med Assoc. 2015 Jan 1;246(1):118-25
Development of a physiologically based pharmacokinetic model for flunixin in cattle (Bos taurus). Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 2014;31(9):1506-21
Tetracycline residues in porcine stomach after administration via drinking water on a swine farm. J Food Prot. 2014 Jan;77(1):122-6
Interspecies mixed-effect pharmacokinetic modeling of penicillin G in cattle and swine. Antimicrob Agents Chemother. 2014 Aug;58(8):4495-503
Effects of new sampling protocols on procaine penicillin G withdrawal intervals for cattle. J Am Vet Med Assoc. 2013 Nov 15;243(10)
Evaluation of factors important in modeling plasma concentrations of tetracycline hydrochloride administered in water in swine. Am J Vet Res. 2012 Oct;73(10):1641-9
Pharmacokinetics and tissue elimination of tulathromycin following subcutaneous administration in meat goats. Am J Vet Res. 2012 Oct;73(10):1634-40
Tulathromycin assay validation and tissue residues after single and multiple subcutaneous injections in domestic goats (Capra aegagrushircus). J. vet. Pharmacol. Therap. 35, 113-120, 2012
Development of a physiologically based pharmacokinetic model to predict tulathromycin distribution in goats. J. vet. Pharmacol. Therap. 35,121–131, 2012
Pharmacokinetics of veterinary drugs in laying hens and residues in eggs: a review of the literature. J Vet Pharmacol Ther. 2011 Dec;34(6):521-56
Pharmacokinetics of flunixin meglumine in swine after intravenous dosing. J Vet Pharmacol Ther. 29(5):437-440, 2006
Use of probabilistic modeling within a physiologically based pharmacokinetic model to predict sulfamethazine residue withdrawal times in edible tissues in swine. Antimicrob Agents Chemother. 2006 Jul;50(7):2344-51
Application of risk assessment and management principles to the extralabel use of drugs in food-producing animals. J Vet Pharmacol Ther. 29(1):5-14, 2006
Development of a physiologic-based pharmacokinetic model for estimating sulfamethazine concentrations in swine and application to prediction of violative residues in edible tissues. Am J Vet Res. 66(10):1686-1693, 2005
Multivariate meta-analysis of pharmacokinetic studies of ampicillin trihydrate in cattle. Am J Vet Res. 66(1):108-112, 2005
Meta-analysis of pharmacokinetic data of veterinary drugs using the Food Animal Residue Avoidance & Depletion Program: oxytetracycline and procaine. J Vet Pharmacol Ther. 27(5):343-353, 2004
A web-based decision support system to estimate extended withdrawal intervals. Computers and Electronics in Agriculture. 44(2):145-151, 2004
Elimination kinetics of ceftiofur hydrochloride after intramammary administration in lactating dairy cows. J Am Vet Med Assoc. 224(11):1827-1830, 2004
Feasibility of using half-life multipliers to estimate extended withdrawal intervals following the extralabel use of drugs in food-producing animals. J Food Prot. 67(3):555-560, 2004
Interspecies considerations in the evaluation of human food safety for veterinary drugs. AAPS PharmSci. 4(4):E34, 2004
Evaluation of the advisory services provided by the Food Animal Residue Avoidance Databank. J Am Vet Med Assoc. 223(11):1596-1598,2003
A physiologically based pharmacokinetic model for oxytetracycline residues in sheep. J Vet Pharmacol Ther. 26(1):55-63,2003
Extrapolated withdrawal-interval estimator (EWE) algorithm: a quantitative approach to establishing extralabel withdrawal times. Regul Toxicol Pharmacol. 36(1):131-137,2002
Mixed-effects modeling of the interspecies pharmacokinetic scaling of oxytetracycline. J Pharm Sci. 91(2):331-341,2002
Mixed effects modeling of the disposition of gentamicin across domestic animal species. J Vet Pharmacol Ther. 24(5):321-332,2001
Estimating provisional acceptable residues for extralabel drug use in livestock. Regul Toxicol Pharmacol. 29(3):287-299,1999
The Food Animal Residue Avoidance Databank (FARAD). Past, present and future. Vet Clin North Am Food Anim Pract. 15(1):75-88,1999
Use of the Food Animal Residue Avoidance Databank (FARAD). J Am Vet Med Assoc. 214(3):344-350,1999
Interspecies allometric analysis of the comparative pharmacokinetics of 44 drugs across veterinary and laboratory animal species. J Vet Pharmacol Ther. (6):453-463,1997
Use of the Food Animal Residue Avoidance Databank. J Am Vet Med Assoc. 198(5):816-819,1991
Food Animal Residue Avoidance Databank (FARAD): a pharmacokinetic-based information resource. J Vet Pharmacol Ther. 9(3):237-245,1986